147 related articles for article (PubMed ID: 2862652)
1. Comparative efficacy of red cell and plasma haloperidol as predictors of clinical response in schizophrenia.
Smith RC; Baumgartner R; Shvartsburd A; Ravichandran GK; Vroulis G; Mauldin M
Psychopharmacology (Berl); 1985; 85(4):449-55. PubMed ID: 2862652
[TBL] [Abstract][Full Text] [Related]
2. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R
Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
[TBL] [Abstract][Full Text] [Related]
3. Plasma and red cell levels of thioridazine and clinical response in schizophrenia.
Smith RC; Baumgartner R; Ravichandran GK; Shvartsburd A; Schoolar JC; Allen P; Johnson R
Psychiatry Res; 1984 Aug; 12(4):287-96. PubMed ID: 6594712
[TBL] [Abstract][Full Text] [Related]
4. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
Neborsky RJ; Janowsky DS; Perel JM; Munson E; Depry D
J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
[TBL] [Abstract][Full Text] [Related]
5. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
[TBL] [Abstract][Full Text] [Related]
6. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J
Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368
[TBL] [Abstract][Full Text] [Related]
7. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
[TBL] [Abstract][Full Text] [Related]
8. Determination of plasma haloperidol concentrations by radioreceptor assay in schizophrenia: clinical utility.
Santos JL; Ramos JA; Prieto P; Almoguera I; Vazquez C; Rubio ME; Cabranes JA
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):917-25. PubMed ID: 2813809
[TBL] [Abstract][Full Text] [Related]
9. Haloperidol plasma levels and dose optimization.
Coryell W; Miller DD; Perry PJ
Am J Psychiatry; 1998 Jan; 155(1):48-53. PubMed ID: 9433338
[TBL] [Abstract][Full Text] [Related]
10. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
[TBL] [Abstract][Full Text] [Related]
11. Effect of subtle neurological dysfunction on response to haloperidol treatment in schizophrenia.
Convit A; Volavka J; Czobor P; de Asis J; Evangelista C
Am J Psychiatry; 1994 Jan; 151(1):49-56. PubMed ID: 8267134
[TBL] [Abstract][Full Text] [Related]
12. The relationship of haloperidol concentrations to therapeutic response.
Perry PJ; Pfohl BM; Kelly MW
J Clin Psychopharmacol; 1988 Feb; 8(1):38-43. PubMed ID: 3350997
[TBL] [Abstract][Full Text] [Related]
13. Lateral ventricular enlargement and clinical response in schizophrenia.
Smith RC; Baumgartner R; Ravichandran GK; Mauldin M; Burd A; Vroulis G; Gordon J; Calderon M
Psychiatry Res; 1985 Mar; 14(3):241-53. PubMed ID: 3858896
[TBL] [Abstract][Full Text] [Related]
14. Pharmacoclinical correlations in schizophrenic patients treated with haloperidol decanoate: clinical evaluations, concentrations of plasma and red blood cell haloperidol and its reduced metabolite, and plasma homovanillic acid.
Aymard N; Viala A; Stein I; Caroli F
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov; 19(7):1119-35. PubMed ID: 8787036
[TBL] [Abstract][Full Text] [Related]
15. Haloperidol plasma levels and clinical response in paranoid schizophrenics.
Linkowski P; Hubain P; von Frenckell R; Mendlewicz J
Eur Arch Psychiatry Neurol Sci; 1984; 234(4):231-6. PubMed ID: 6526061
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine versus haloperidol treatment in first-episode psychosis.
Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
[TBL] [Abstract][Full Text] [Related]
17. Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia.
Balant-Gorgia AE; Eisele R; Balant L; Garrone G
Eur Arch Psychiatry Neurol Sci; 1984; 234(1):1-4. PubMed ID: 6489392
[TBL] [Abstract][Full Text] [Related]
18. Haloperidol and reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients.
Ko GN; Korpi ER; Kirch DG
J Clin Psychopharmacol; 1989 Jun; 9(3):186-90. PubMed ID: 2661607
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic window of serum haloperidol concentration in acute schizophrenia and schizoaffective disorder.
Ulrich S; Neuhof S; Braun V; Meyer FP
Pharmacopsychiatry; 1998 Sep; 31(5):163-9. PubMed ID: 9832347
[TBL] [Abstract][Full Text] [Related]
20. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
